Enteris BioPharma’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

Enteris BioPharma is a biopharmaceutical company that develops peptide-based oral therapeutics for the treatment of metabolic disorders. Read more

Enteris BioPharma is a biopharmaceutical company that develops peptide-based oral therapeutics for the treatment of metabolic disorders. Read more

Rajiv Khosla's photo - President & CEO of Enteris BioPharma

President & CEO

Rajiv Khosla

CEO Approval Rating

90/100

Founded:

2013

Status:

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Antag Therapeutics is Enteris BioPharma's top competitor. Antag Therapeutics is a Private company that was founded in Copenhagen, Capital Region in 2017. Antag Therapeutics operates in the Pharmaceuticals industry. Antag Therapeutics has 10 fewer employees vs. Enteris BioPharma.

ACADIA has been one of Enteris BioPharma's top competitors. ACADIA is headquartered in San Diego, California, and was founded in 1993. ACADIA is in the Biotechnology field. ACADIA generates 3,418% the revenue of Enteris BioPharma.

Cognition Therapeutics is perceived as one of Enteris BioPharma's biggest rivals. Cognition Therapeutics was founded in 2007 in Pittsburgh, Pennsylvania. Cognition Therapeutics competes in the Biotechnology field. Cognition Therapeutics generates $5.9M less revenue than Enteris BioPharma.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is $11.5M a good estimate for Enteris BioPharma's revenue?

Acquisitions

No recent acquisitions found related to Enteris BioPharma

Investments

No recent investments found related to Enteris BioPharma

Enteris BioPharma News

January 6, 2020MarketScreener

Enteris BioPharma Highlights 2019 Achievements and 2020 Outlook

(marketscreener.com) BOONTON, N.J., Jan. 6, 2020 /PRNewswire/ -- Acquired by SWK Holdings Corporation... See more »
August 29, 2019BioPortfolio

Licensing agreement formalizes drug delivery technology partnership

Enteris enters a licensing agreement with Cara Therapeutics for the ongoing development of the latter... See more »
August 28, 2019NJB Magazine

SWK Holdings Corporation Acquires Enteris BioPharma

SWK Holdings Corporation, a life science focused specialty finance company, and Boonton-based Enteris... See more »
September 27, 2018BioPortfolio

Enteris BioPharma Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13082018 Prices from USD $250

SummaryEnteris BioPharma Inc Enteris is a biotechnology company that offers formulation solutions bas... See more »
July 19, 2018PharmiWeb

Enteris BioPharma's "Feasibility-to-Licensing" Partner, Cara Therapeutics, Doses First Patient in Phase 2 Trial of Peptelligence®-Engineered Oral KORSUVA

Enteris BioPharma's "Feasibility-to-Licensing" Partner, Cara Therapeutics, Doses First Patient in Pha... See more »
June 26, 2018Drug Delivery Business

Enteris BioPharma touts more Phase II data for oral endometriosis therapy

Enteris BioPharma this week touted positive results from the final treatment arm of a Phase IIa trial... See more »
April 30, 2018BioPortfolio

Syneos taking Enteriss endometriosis treatment to Ph IIa

Enteris BioPharma has completed recruitment and initial dosing of all subjects for an additional trea... See more »

Enteris BioPharma Press Releases

December 18, 2018PR Newswire

Enteris BioPharma to Present at Biotech Showcase 2019

BOONTON, N.J., Dec. 18, 2018 /PRNewswire/ -- Enteris BioPharma, Inc., a biotechnology company develop... See more »
April 30, 2018ForImmediateRelease

Enteris BioPharma Announces Completion of Recruitment in Expanded Phase 2a Clinical Trial of Ovarest® (oral leuprolide tablet) for Endometriosis

Travel & Tourism Industry release: BOONTON, N.J., April 30, 2018 /PRNewswire/ - Enteris BioPharma, In... See more »
March 15, 2018ForImmediateRelease

Enteris BioPharma to Present at the 25th Annual Future Leaders in the Biotech Industry Conference

Travel & Tourism Industry release: BOONTON, N.J., March 15, 2018 /PRNewswire/ - Enteris BioPharma, In... See more »
March 5, 2018PR Newswire

Enteris BioPharma Initiates Feasibility Program with Ferring Pharmaceuticals to Develop an Oral Formulation of a Peptide

BOONTON, N.J., March 5, 2018 /PRNewswire/ -- Enteris BioPharma, Inc., a biotechnology company develop... See more »
September 19, 2017PR Newswire

Enteris BioPharma to Present at BioPharm America

BOONTON, N.J., Sept. 19, 2017 /PRNewswire/ -- Enteris BioPharma, Inc., a biotechnology company develo... See more »
June 13, 2017PR Newswire

Enteris BioPharma to Present at BIO 2017

BOONTON, N.J., June 13, 2017 /PRNewswire/ -- Enteris BioPharma, Inc., a biotechnology company develop... See more »

Social Statistics

Headquarters

83 Fulton Street

Boonton, New Jersey07005

973-453-3518

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Enteris BioPharma is a biopharmaceutical company that develops peptide-based oral therapeutics for the treatment of metabolic disorders. Enteris BioPharma was founded in 2013. Enteris BioPharma's headquarters is located in Boonton, New Jersey, USA 070...

CEO

Enteris BioPharma's President & CEO, Rajiv Khosla, currently has an approval rating of 90%. Enteris BioPharma's primary competitors are Antag Therapeutics, ACADIA & Cognition Therapeutics.

Website

enterisbiopharma.com

Frequently Asked Questions about Enteris BioPharma

  1. When was Enteris BioPharma founded?

    Enteris BioPharma was founded in 2013
  2. Who is Enteris BioPharma's CEO?

    Enteris BioPharma's CEO is Rajiv Khosla
  3. How much revenue does Enteris BioPharma generate?

    Enteris BioPharma generates $11.5M in revenue
  4. How much funding does Enteris BioPharma have?

    Enteris BioPharma has historically raised $0 in funding
  1. Where is Enteris BioPharma's headquarters?

    Enteris BioPharma's headquarters is in Boonton New Jersey, USA
  2. How many employees does Enteris BioPharma have?

    Enteris BioPharma has 25 employees
  3. What sector does Enteris BioPharma operate in?

    Enteris BioPharma is in Biotechnology
  4. Who are Enteris BioPharma's competitors?

    Enteris BioPharma's top competitors are Antag Therapeutics, ACADIA, Cognition Therapeutics